Puriblood Medical Co., Ltd.
6847.TWO
6847.TWOPuriblood Medical Co., Ltd.
Taiwan Stock Exchange78.00
TWD
-0.20
(-0.26%)
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Luke Chen
- Full Time Employees
- 44
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- Address
- No.11, Gongye East 9th Road Hsinchu City Taiwan, Province of China 300096
- IPO Date
- Nov 5, 2021
- Website
- puriblood.com
- Similar Companies
- Business
- Puriblood Medical Co., Ltd. develops and sells blood cell separation products in Taiwan. The company offers leukocyte reduction filters for red blood cells, platelets, and whole blood, as well as real-time filtration sets for whole blood. It also offers Devin blood fractionation membrane filters and Minipuri cell screening syringe filters. In addition, the company develops P-Tex Technology, which is composed by bio-inspired molecular formula zwitterionic copolymer structure. Puriblood Medical Co., Ltd. was founded in 2016 and is based in Hsinchu City, Taiwan.